NurExone ExoTherapy Platform
for Noninvasive Nanodrugs
Exosome
The company’s dedicated in-house bioreactor produces potent exosomes with high quality and large scale using proprietary 2D and 3D production processes.
Active Pharmaceutical Ingredient (API)
The company’s team of biologists and PhDs sysnthesizes compounds with therapeutic properties and active pharmaceutical ingredients
Nanodrug
Nanodrugs are created by loading the therapeutic compound onto exosomes (short peptides, molecules). Known APIs can be repurposed and loaded onto the exosomes under a proprietary loading process.
